Of interest, the upregulation of total PKCα protein and downregulation of total β-catenin by the NDRG1-inducing therapeutics, DpC and DFO, was also demonstrated in SK-Mel-28 melanoma cells (Fig. S2A). This evidence concerns the gene PRKCA and melanoma.